Cost-Effectiveness of a Community-Based Diabetes Prevention Program with Participation Incentives for Medicaid Beneficiaries

Health Services Research
Todd GilmerJay Desai

Abstract

To examine the cost-effectiveness of a community-based Diabetes Prevention Program (DPP) for Medicaid beneficiaries from the perspective of the health care sector. A total of 847 Medicaid enrollees at high risk for type 2 diabetes participating in a community-based DPP. Pre- and post clinical outcome and cost data were used as inputs into a validated diabetes simulation model. The model was used to evaluate quality-adjusted life years (QALYs) and health care costs over a 40-year time horizon from the perspective of the health care sector. Clinical outcome and cost data were derived from a study examining the effect of financial incentives on weight loss. Study participants lost an average of 4.2 lb (p < .001) and increased high-density lipoprotein cholesterol by 1.75 mg/dl (p = .002). Intervention costs, which included financial incentives for participation and weight loss, were $915 per participant. The incremental cost-effectiveness ratio was estimated to be $14,011 per QALY but was sensitive to the time horizon studied. Widespread adoption of community-based DPP has the potential to reduce diabetes and cardiovascular-related morbidity and mortality for low-income persons at high risk for diabetes and may be a cost-effective ...Continue Reading

References

Feb 8, 2002·The New England Journal of Medicine·William C KnowlerUNKNOWN Diabetes Prevention Program Research Group
Mar 2, 2005·Annals of Internal Medicine·William H HermanUNKNOWN Diabetes Prevention Program Research Group
Aug 17, 2005·Annals of Internal Medicine·David M EddyRichard Kahn
Aug 19, 2007·Diabetes Care·Thomas J HoergerMichael M Engelgau
Sep 10, 2008·American Journal of Preventive Medicine·Ronald T AckermannDavid G Marrero
Dec 11, 2008·JAMA : the Journal of the American Medical Association·Kevin G VolppGeorge Loewenstein
Mar 27, 2009·The Diabetes Educator·Helen A AmundsonUNKNOWN Montana Cardiovascular Disease and Diabetes Prevention Program Workgroup
Nov 27, 2009·Diabetes Care·Elbert S HuangJames C Capretta
Apr 7, 2010·Progress in Community Health Partnerships : Research, Education, and Action·Marjorie K MauHenry Gomes
Oct 1, 2010·The New England Journal of Medicine·Howard K Koh, Kathleen G Sebelius
Sep 15, 2011·The New England Journal of Medicine·Thomas R Frieden, Donald M Berwick
Mar 27, 2013·American Journal of Preventive Medicine·Ann L Albright, Edward W Gregg
Mar 27, 2013·American Journal of Preventive Medicine·Ronald T Ackermann
Apr 3, 2013·Annals of Internal Medicine·Jeffrey T KullgrenKevin G Volpp
Aug 30, 2013·Cost Effectiveness and Resource Allocation : C/E·Inna FeldmanPia Johansson
Sep 1, 2011·Translational Behavioral Medicine·Robin Whittemore
Apr 18, 2014·The New England Journal of Medicine·Edward W GreggLinda Geiss
Apr 26, 2015·Journal of Immigrant and Minority Health·Daniel L HallPatrice G Saab
Sep 9, 2015·JAMA : the Journal of the American Medical Association·Andy MenkeCatherine C Cowie
Sep 18, 2015·American Journal of Public Health·Ronald T AckermannChandan Saha
Oct 29, 2015·North Carolina Medical Journal·Thomas J HoergerStephanie Teixeira-Poit

❮ Previous
Next ❯

Citations

Dec 22, 2019·Diabetes Care·UNKNOWN American Diabetes Association
Sep 10, 2020·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Natalie D RitchieKatherine A Sauder
Dec 11, 2020·Diabetes Care·UNKNOWN American Diabetes Association

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.